{"id":"NCT02583256","sponsor":"Seqirus","briefTitle":"Clinical Study to Evaluate Safety, Immunogenicity of Investigational Flu Vaccine Compared to an Approved Flu Vaccine in Children Previously Vaccinated in Trial V118_05 (NCT01964989)","officialTitle":"A Phase III, Randomized, Observer Blind, Multicenter Study to Evaluate the Safety and Immunogenicity of Repeated Exposure to Either the Same or Alternate Type of Vaccine, Adjuvanted or Non-adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV or QIV), Administered to Subjects Previously Vaccinated in Trial V118_05 (NCT01964989)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-01-29","primaryCompletion":"2016-11-15","completion":"2017-05-09","firstPosted":"2015-10-22","resultsPosted":"2019-04-24","lastUpdate":"2019-04-24"},"enrollment":1601,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Influenza"],"interventions":[{"type":"BIOLOGICAL","name":"Adjuvanted QIV (aQIV)","otherNames":[]},{"type":"BIOLOGICAL","name":"Non-adjuvanted QIV","otherNames":[]}],"arms":[{"label":"aQIV/aQIV","type":"EXPERIMENTAL"},{"label":"aQIV/QIV","type":"EXPERIMENTAL"},{"label":"QIV/aQIV","type":"EXPERIMENTAL"},{"label":"QIV/QIV","type":"EXPERIMENTAL"}],"summary":"Safety, Immunogenicity of an Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine Compared to Non-Adjuvanted Comparator Influenza Vaccine in Children Previously vaccinated in Trial V118\\_05. Subjects will receive either the Same or Alternate Type of Vaccine.","primaryOutcome":{"measure":"Immunogenicity Endpoint: Geometric Mean Titer (GMT) and GMT Ratio as Determined by Hemagglutination Inhibition (HI) Assay on Day 22 Against Homologous Strains (aQIV-primed Comparison), Noninferiority Analysis","timeFrame":"Day 22","effectByArm":[{"arm":"aQIV/aQIV","deltaMin":1219,"sd":null},{"arm":"aQIV/QIV","deltaMin":1020.89,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"12 Months","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":3},"locations":{"siteCount":17,"countries":["Finland","Philippines","Thailand"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":10,"n":403},"commonTop":["Injection Site Pain","Upper Respiratory Tract Infection","Pyrexia","Injection Site Erythema","Somnolence"]}}